Found: 6
Select item for more details and to access through your institution.
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63894-z
- By:
- Publication type:
- Article
Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01324
- By:
- Publication type:
- Article
Development and evaluation of a rapid visual loop-mediated isothermal amplification assay for the tcdA gene in Clostridioides difficile detection.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17776
- By:
- Publication type:
- Article
Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 3, p. 266, doi. 10.1177/1724600818760234
- By:
- Publication type:
- Article
The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth‐based quadruple therapy.
- Published in:
- Helicobacter, 2021, v. 26, n. 1, p. 1, doi. 10.1111/hel.12768
- By:
- Publication type:
- Article
Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial.
- Published in:
- Helicobacter, 2019, v. 24, n. 2, p. N.PAG, doi. 10.1111/hel.12566
- By:
- Publication type:
- Article